DM
Deerfield Management Portfolio holdings
AUM
$5.51B
1-Year Return
12.76%
This Quarter Return
+18.6%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$6.69B
AUM Growth
+$682M
(+11%)
Cap. Flow
-$874M
Cap. Flow
% of AUM
-13.05%
Top 10 Holdings %
Top 10 Hldgs %
54.02%
Holding
681
New
246
Increased
85
Reduced
72
Closed
235
Top Buys
| 1 |
Neurocrine Biosciences
NBIX
|
$72.1M |
| 2 |
Indivior
INDV
|
$49.7M |
| 3 |
BCAX
Bicara Therapeutics Inc. Common Stock
BCAX
|
$45.7M |
| 4 |
Merus
MRUS
|
$32.9M |
| 5 |
Viatris
VTRS
|
$30.2M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$102M |
| 2 |
Surgery Partners
SGRY
|
$94.4M |
| 3 |
Catalyst Pharmaceutical
CPRX
|
$57.6M |
| 4 |
BioNTech
BNTX
|
$49.8M |
| 5 |
Integra LifeSciences
IART
|
$42.8M |
Sector Composition
| 1 | Healthcare | 87.45% |
| 2 | Industrials | 0.72% |
| 3 | Technology | 0.55% |
| 4 | Financials | 0.42% |
| 5 | Consumer Discretionary | 0.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
626
Golub Capital BDC
GBDC
$3.92B
| – | – |
-67,056
| Closed | -$1.05M |
|
627
GoodRx Holdings
GDRX
$1.42B
| – | – |
-22,123
| Closed | -$173K |
|
|
628
Gilead Sciences
GILD
$143B
| – | – |
-1,491,000
| Closed | -$102M |
|
629
Alphabet (Google) Class A
GOOGL
$2.82T
| – | – |
-1,340
| Closed | -$244K |
|
630
Haemonetics
HAE
$2.62B
| – | – |
-6,036
| Closed | -$499K |
|
631
Hain Celestial
HAIN
$162M
| – | – |
-124,589
| Closed | -$861K |
|
632
Health Catalyst
HCAT
$234M
| – | – |
-13,508
| Closed | -$86.3K |
|
633
Warrior Met Coal
HCC
$3.16B
| – | – |
-14,264
| Closed | -$895K |
|
634
HCI Group
HCI
$2.2B
| – | – |
-9,779
| Closed | -$901K |
|
635
Home Depot
HD
$416B
| – | – |
-1,923
| Closed | -$662K |
|
636
Hologic
HOLX
$14.8B
| – | – |
-13,734
| Closed | -$1.02M |
|
637
Robinhood
HOOD
$89.2B
| – | – |
-10,823
| Closed | -$246K |
|
638
Healthcare Realty
HR
$6.31B
| – | – |
-28,566
| Closed | -$471K |
|
639
Henry Schein
HSIC
$8.37B
| – | – |
-13,479
| Closed | -$864K |
|
640
HealthStream
HSTM
$831M
| – | – |
-22,437
| Closed | -$626K |
|
641
Hershey
HSY
$37.8B
| – | – |
-5,032
| Closed | -$925K |
|
642
Humacyte
HUMA
$228M
| – | – |
-322,851
| Closed | -$1.55M |
|
643
Hexcel
HXL
$5.11B
| – | – |
-23,879
| Closed | -$1.49M |
|
|
644
Integra LifeSciences
IART
$1.25B
| – | – |
-1,467,632
| Closed | -$42.8M |
|
|
ILPT
645
Industrial Logistics Properties Trust
ILPT
$404M
| – | – |
-147,321
| Closed | -$542K |
|
646
Immersion
IMMR
$228M
| – | – |
-56,830
| Closed | -$535K |
|
647
Innodata
INOD
$1.37B
| – | – |
-111,814
| Closed | -$1.66M |
|
648
Inspire Medical Systems
INSP
$2.57B
| – | – |
-2,813
| Closed | -$376K |
|
649
Intuit
INTU
$187B
| – | – |
-2,197
| Closed | -$1.44M |
|
|
INZY
650
DELISTED
Inozyme Pharma
INZY
| – | – |
-11,591
| Closed | -$51.7K |
|